Evaluation of plasma neurotoxin concentration in uraemic polyneuropathic patients. 1978

N K Man, and G Cueille, and J Zingraff, and T Drueke, and P Jungers, and A Sausse, and J Boudet, and J L Funck-Brentano

Purification of b4-2 sub-peak obtained on DEAE Sephadex A25 chromatography gave us the possibility of quantifying the plasma concentration of the neurotoxin present in uraemic patients with active polyneuropathy. From the purified neurotoxin isolated by kieselguhr and cellulose chromatography we calibrated analytic columns for b4-2 analysis. Plasma concentration, measured in 6 uraemic neuropathic patients, is between 13 and 19 mg/litre. In 52 uraemic patients without neuropathy, the plasma concentration is between 3 and 9 mg/litre. In 20 healthy subjects the plasma concentration is less than 1 mg/litre. The weekly neurotoxin removal in uraemic patients without neuropathy, treated by a five hours RP6 session 3 times a week, is of the same order of magnitude as the weekly urinary excretion in healthy subjects. Preliminary results of a tentative identification of this purified product indicate that it is not a polypeptide but an acid-polyol with carbohydrate structure.

UI MeSH Term Description Entries
D009498 Neurotoxins Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept. Alpha-Neurotoxin,Excitatory Neurotoxin,Excitotoxins,Myotoxin,Myotoxins,Neurotoxin,Alpha-Neurotoxins,Excitatory Neurotoxins,Excitotoxin,Alpha Neurotoxin,Alpha Neurotoxins,Neurotoxin, Excitatory,Neurotoxins, Excitatory
D010523 Peripheral Nervous System Diseases Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves. Peripheral Nerve Diseases,Peripheral Neuropathies,PNS (Peripheral Nervous System) Diseases,PNS Diseases,Peripheral Nervous System Disease,Peripheral Nervous System Disorders,Nerve Disease, Peripheral,Nerve Diseases, Peripheral,Neuropathy, Peripheral,PNS Disease,Peripheral Nerve Disease,Peripheral Neuropathy
D002852 Chromatography, Ion Exchange Separation technique in which the stationary phase consists of ion exchange resins. The resins contain loosely held small ions that easily exchange places with other small ions of like charge present in solutions washed over the resins. Chromatography, Ion-Exchange,Ion-Exchange Chromatography,Chromatographies, Ion Exchange,Chromatographies, Ion-Exchange,Ion Exchange Chromatographies,Ion Exchange Chromatography,Ion-Exchange Chromatographies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014511 Uremia A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms. Uremias

Related Publications

N K Man, and G Cueille, and J Zingraff, and T Drueke, and P Jungers, and A Sausse, and J Boudet, and J L Funck-Brentano
January 1979, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
N K Man, and G Cueille, and J Zingraff, and T Drueke, and P Jungers, and A Sausse, and J Boudet, and J L Funck-Brentano
December 1978, Scandinavian journal of clinical and laboratory investigation,
N K Man, and G Cueille, and J Zingraff, and T Drueke, and P Jungers, and A Sausse, and J Boudet, and J L Funck-Brentano
June 1968, Lancet (London, England),
N K Man, and G Cueille, and J Zingraff, and T Drueke, and P Jungers, and A Sausse, and J Boudet, and J L Funck-Brentano
October 1986, Acta pharmacologica et toxicologica,
N K Man, and G Cueille, and J Zingraff, and T Drueke, and P Jungers, and A Sausse, and J Boudet, and J L Funck-Brentano
January 1999, Nephron,
N K Man, and G Cueille, and J Zingraff, and T Drueke, and P Jungers, and A Sausse, and J Boudet, and J L Funck-Brentano
March 2000, Nephron,
N K Man, and G Cueille, and J Zingraff, and T Drueke, and P Jungers, and A Sausse, and J Boudet, and J L Funck-Brentano
February 1982, Clinica chimica acta; international journal of clinical chemistry,
N K Man, and G Cueille, and J Zingraff, and T Drueke, and P Jungers, and A Sausse, and J Boudet, and J L Funck-Brentano
January 1967, Acta neurologica Scandinavica,
N K Man, and G Cueille, and J Zingraff, and T Drueke, and P Jungers, and A Sausse, and J Boudet, and J L Funck-Brentano
March 2000, Nephron,
N K Man, and G Cueille, and J Zingraff, and T Drueke, and P Jungers, and A Sausse, and J Boudet, and J L Funck-Brentano
June 1979, Annals of clinical research,
Copied contents to your clipboard!